Global Blue Group
GB
$4.64
Share price
-3.13%
Change (1 day)
-8.48%
Change (1 year)
Categories
Global Blue Group (GB) - Cash on Hand
Cash on Hand as of March 2024 : $94.39 M
According to Global Blue Group's latest financial reports the company has $94.39 M in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Global Blue Group - Cash on Hand chart (from 2020 to 2024)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-03-31 | $0.26 B | 360.04% |
| 2022-03-31 | $57.01 M | -73.39% |
| 2021-03-31 | $0.21 B | -14.09% |
| 2020-03-31 | $0.24 B | 113.55% |
| 2019-03-31 | $0.11 B | 87.19% |
| 2018-03-31 | $62.4 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $26.21 B | 27,674.69% | 🇺🇸 USA |
 Medtronic MDT | $8.32 B | 8,715.06% | 🇮🇪 Ireland |
 Boston Scientific BSX | $2.32 B | 2,367.28% | 🇺🇸 USA |
 Edwards Lifesciences EW | $1.69 B | 1,698.39% | 🇺🇸 USA |
 Stryker Corporation SYK | $2.40 B | 2,449.92% | 🇺🇸 USA |